NTx announces expansion of Board of Directors & completion of funding round led by Convergent Ventures
Summary
Zachariah Jonasson is currently the CFO and CBO of Absci Corp., a biotechnology company that uses generative AI at scale to create novel therapeutics. Companies that spun out of INEX include Protiva Biotherapeutics and Tekmira, which was later rebranded as Arbutus Biopharma.These strategic developments the recent partnership announcement, new funding and expansion of the board significantly enhance NanoVations position as a leading innovator in nucleic acid delivery, said Pieter Cullis, Ph.D., current Board Chair and co-founder of NanoVation. Welcoming seasoned entrepreneurs like David and Zach strengthens our team, bringing invaluable business acumen that complements our technical expertise. NanoVations lead technology is its proprietary long-circulating LNP (lcLNP) platform, which enables functional nucleic acid delivery to extrahepatic cell types and has demonstrated an improved therapeutic index in preclinical studies. NanoVation partners with leading pharmaceutical and biotech companies to enable the development of genetic medicines for previously untreatable diseases.